ATHE Stock Analysis: Buy, Sell, or Hold?
ATHE - Alterity Therapeutics Limited American Depositary Shares
$4.96
0.03 (0.61%)
▲
5d:
+12.47%
30d:
+18.66%
90d:
+50.3%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Get Alerted When ATHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ATHE is 7.1% above its trading range ($4.63). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ATHE is 7.1% above its trading range ($4.63). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ATHE is currently trading at $4.96, which is considered extended relative to its 30-day fair value range of $3.93 to $4.63.
Technical Outlook: Technically, ATHE is in a strong uptrend. Immediate support is located at $3.95, while resistance sits at $5.30.
Market Sentiment: ATHE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+121.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATHE is in a strong uptrend. Immediate support is located at $3.95, while resistance sits at $5.30.
Market Sentiment: ATHE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+121.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.93 -
$4.63
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+7.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 121.8% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$3.93 -
$4.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.95
Resistance Level
$5.30
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.20
Wall Street Target
$11.00
(+121.8%)
Revenue Growth (YoY)
74.6%
Profit Margin
-219.9%
Share & Embed Analysis
Last updated: June 24, 2026 2:35 AM ET
Data refreshes hourly during market hours. Next update: 3:35 AM
Data refreshes hourly during market hours. Next update: 3:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
